Skip to main content
Top
Published in: International Journal of Health Economics and Management 3-4/2019

01-12-2019 | Care | Research Article

Using disability adjusted life years to value the treatment of thirty chronic conditions in the U.S. from 1987 to 2010: a proof of concept

Authors: Tina Highfill, Elizabeth Bernstein

Published in: International Journal of Health Economics and Management | Issue 3-4/2019

Login to get access

Abstract

Health care spending in the U.S. grew two trillion dollars from 1987 to 2010, a 400% increase, but our understanding of the value of that increase is limited. In this paper we estimate the net value of spending for thirty chronic diseases between 1987 and 2010 by assigning a monetary value to changes in health outcomes and relating it to the costs of treating each disease. Changes in health outcomes are measured using a newly-available time series of disability adjusted life years (DALYs) data from the Institute for Health Metrics and Evaluation. Spending on treatments are determined using health care expenditure data from nationally representative surveys. We find the net value of treatment has grown substantially for several diseases. Overall, 20 of the 30 chronic conditions studied experienced an increase in health outcomes over the period, with 8 of those 20 showing a decrease in per-patient spending. Our estimates of net value of health spending using DALYs data are simple to apply and results are generally consistent with previous estimates which usually involve onerous data collection methods to study a single disease. The DALYs data have potential to be a useful, low-cost way to measure changes in health outcomes. However, challenges remain in using DALYs data to accurately measure the changing value of health care spending on the treatment of disease.
Literature
go back to reference Aizcorbe, A., Bradley, R., Greenaway-McGrevy, R., Herauf, B., Kane, R., Liebman, E., Pack, S., & Rozental, L. (2011). Alternative price indexes for medical care: Evidence from the MEPS survey. U.S. Bureau of Economic Analysis working paper WP2011-01, Washington, DC. Aizcorbe, A., Bradley, R., Greenaway-McGrevy, R., Herauf, B., Kane, R., Liebman, E., Pack, S., & Rozental, L. (2011). Alternative price indexes for medical care: Evidence from the MEPS survey. U.S. Bureau of Economic Analysis working paper WP2011-01, Washington, DC.
go back to reference Aizcorbe, A., Liebman, E., Cutler, D. M., & Rosen, A. B. (2012). Household consumption expenditures for medical care: An alternate presentation. Survey of Current Business,92(6), 34–48. Aizcorbe, A., Liebman, E., Cutler, D. M., & Rosen, A. B. (2012). Household consumption expenditures for medical care: An alternate presentation. Survey of Current Business,92(6), 34–48.
go back to reference Alzheimer’s Association, Thies, W., & Bleiler, L. (2011). 2011 Alzheimer’s disease facts and figures. Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association,7(2), 208–244.CrossRef Alzheimer’s Association, Thies, W., & Bleiler, L. (2011). 2011 Alzheimer’s disease facts and figures. Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association,7(2), 208–244.CrossRef
go back to reference Berry, S., Ngo, L., Samelson, E., & Kiel, D. (2010). Competing risk of death: An important consideration in studies of older adults. Journal of the American Geriatrics Society,58(4), 783–787.CrossRef Berry, S., Ngo, L., Samelson, E., & Kiel, D. (2010). Competing risk of death: An important consideration in studies of older adults. Journal of the American Geriatrics Society,58(4), 783–787.CrossRef
go back to reference Bunker, J. P. (2001). The role of medical care in contributing to health improvements within societies. International Journal of Epidemiology,30(6), 1260–1263.CrossRef Bunker, J. P. (2001). The role of medical care in contributing to health improvements within societies. International Journal of Epidemiology,30(6), 1260–1263.CrossRef
go back to reference Cutler, D. M., McClellan, M., Newhouse, J. P., & Remler, D. (1998). Are medical prices declining? Evidence from heart attack treatments. The Quarterly Journal of Economics,113(4), 991–1024.CrossRef Cutler, D. M., McClellan, M., Newhouse, J. P., & Remler, D. (1998). Are medical prices declining? Evidence from heart attack treatments. The Quarterly Journal of Economics,113(4), 991–1024.CrossRef
go back to reference Cutler, D. M., McClellan, M. B., Newhouse, J. P., & Remler, D. (2001). Pricing heart attack treatments. In D. M. Cutler & E. R. Berndt (Eds.), Medical care output and productivity (pp. 305–362). Chicago: University of Chicago Press.CrossRef Cutler, D. M., McClellan, M. B., Newhouse, J. P., & Remler, D. (2001). Pricing heart attack treatments. In D. M. Cutler & E. R. Berndt (Eds.), Medical care output and productivity (pp. 305–362). Chicago: University of Chicago Press.CrossRef
go back to reference Cutler, D., Rosen, A. B., & Vijan, S. (2006). The value of medical spending in the United States, 1960–2000. New England Journal of Medicine,355(9), 920–927.CrossRef Cutler, D., Rosen, A. B., & Vijan, S. (2006). The value of medical spending in the United States, 1960–2000. New England Journal of Medicine,355(9), 920–927.CrossRef
go back to reference Deuschl, G., Schade-Brittinger, C., Krack, P., Volkmann, J., Schäfer, H., Bötzel, K., et al. (2006). A randomized trial of deep-brain stimulation for Parkinson’s disease. New England Journal of Medicine,355(9), 896–908.CrossRef Deuschl, G., Schade-Brittinger, C., Krack, P., Volkmann, J., Schäfer, H., Bötzel, K., et al. (2006). A randomized trial of deep-brain stimulation for Parkinson’s disease. New England Journal of Medicine,355(9), 896–908.CrossRef
go back to reference Eggleston, K. N., Shah, N. D., Smith, S. A., Berndt, E. R., & Newhouse, J. P. (2011). Quality adjustment for health care spending on chronic disease: Evidence from diabetes treatment, 1999–2009. The American Economic Review,101(3), 206–211.CrossRef Eggleston, K. N., Shah, N. D., Smith, S. A., Berndt, E. R., & Newhouse, J. P. (2011). Quality adjustment for health care spending on chronic disease: Evidence from diabetes treatment, 1999–2009. The American Economic Review,101(3), 206–211.CrossRef
go back to reference Fasano, A., Daniele, A., & Albanese, A. (2012). Treatment of motor and non-motor features of Parkinson’s disease with deep brain stimulation. The Lancet Neurology,11(5), 429–442.CrossRef Fasano, A., Daniele, A., & Albanese, A. (2012). Treatment of motor and non-motor features of Parkinson’s disease with deep brain stimulation. The Lancet Neurology,11(5), 429–442.CrossRef
go back to reference Hall, A. E., & Highfill, T. (2013). Calculating disease-based medical care expenditure indexes for medicare beneficiaries: A comparison of method and data choices. National Bureau of Economic Research working paper no. 19720, Cambridge, MA. Hall, A. E., & Highfill, T. (2013). Calculating disease-based medical care expenditure indexes for medicare beneficiaries: A comparison of method and data choices. National Bureau of Economic Research working paper no. 19720, Cambridge, MA.
go back to reference Institute for Health Metrics and Evaluation. (2010). The global burden of disease. University of Washington. Institute for Health Metrics and Evaluation. (2010). The global burden of disease. University of Washington.
go back to reference James, B. D., Leurgans, S. E., Hebert, L. E., Scherr, P. A., Yaffe, K., & Bennett, D. A. (2014). Contribution of Alzheimer disease to mortality in the United States. Neurology,82(12), 1045–1050.CrossRef James, B. D., Leurgans, S. E., Hebert, L. E., Scherr, P. A., Yaffe, K., & Bennett, D. A. (2014). Contribution of Alzheimer disease to mortality in the United States. Neurology,82(12), 1045–1050.CrossRef
go back to reference Medical Expenditure Panel Survey. (2010). Agency for healthcare research and quality. Household full year file, 2010. [Internet]. Rockville, MD: AHRQ. Medical Expenditure Panel Survey. (2010). Agency for healthcare research and quality. Household full year file, 2010. [Internet]. Rockville, MD: AHRQ.
go back to reference Murray, C. J., Abraham, J., Ali, M. K., Alvarado, M., Atkinson, C., Baddour, L. M., et al. (2013). The state of US health, 1990–2010: Burden of diseases, injuries, and risk factors. Journal of the American Medical Association,310(6), 591–608.CrossRef Murray, C. J., Abraham, J., Ali, M. K., Alvarado, M., Atkinson, C., Baddour, L. M., et al. (2013). The state of US health, 1990–2010: Burden of diseases, injuries, and risk factors. Journal of the American Medical Association,310(6), 591–608.CrossRef
go back to reference National Medical Expenditure Survey. (1987). Household survey, health status questionnaire, and access to care supplement [public use tape 9] (ICPSR 9674) [Internet]. Ann Arbor, MI: University of Michigan Institute for Social Research. National Medical Expenditure Survey. (1987). Household survey, health status questionnaire, and access to care supplement [public use tape 9] (ICPSR 9674) [Internet]. Ann Arbor, MI: University of Michigan Institute for Social Research.
go back to reference Olazaran, J., Reisberg, B., Clare, L., Cruz, I., Pena-Casanova, J., Del Ser, T., et al. (2010). Nonpharmacological therapies in Alzheimer’s disease: A systematic review of efficacy. Dementia and Geriatric Cognitive Disorders,30(2), 161–178.CrossRef Olazaran, J., Reisberg, B., Clare, L., Cruz, I., Pena-Casanova, J., Del Ser, T., et al. (2010). Nonpharmacological therapies in Alzheimer’s disease: A systematic review of efficacy. Dementia and Geriatric Cognitive Disorders,30(2), 161–178.CrossRef
go back to reference Organisation for Economic Co-operation and Development, Statistics Directorate. (2010). Towards measuring the volume output of education and health services: A handbook. Working paper number 31. Organisation for Economic Co-operation and Development, Statistics Directorate. (2010). Towards measuring the volume output of education and health services: A handbook. Working paper number 31.
go back to reference Porter, M. E. (2010). What is value in health care? New England Journal of Medicine,363(26), 2477–2481.CrossRef Porter, M. E. (2010). What is value in health care? New England Journal of Medicine,363(26), 2477–2481.CrossRef
go back to reference Roehrig, C., Miller, G., Lake, C., & Bryant, J. (2009). National health spending by medical condition, 1996–2005. Health Affairs,28(2), w358–w367.CrossRef Roehrig, C., Miller, G., Lake, C., & Bryant, J. (2009). National health spending by medical condition, 1996–2005. Health Affairs,28(2), w358–w367.CrossRef
go back to reference Rosen, A. B., Aizcorbe, A., Highfill, T., Chernew, M. E., Liebman, E., Ghosh, K., et al. (2018). Attribution of health care costs to diseases. Measuring and Modeling Health Care Costs,76, 173. Rosen, A. B., Aizcorbe, A., Highfill, T., Chernew, M. E., Liebman, E., Ghosh, K., et al. (2018). Attribution of health care costs to diseases. Measuring and Modeling Health Care Costs,76, 173.
go back to reference Shapiro, I., Shapiro, M. D., & Wilcox, D. (2001). Measuring the value of cataract surgery. In D. M. Cutler & E. R. Berndt (Eds.), Medical care output and productivity (pp. 411–438). Chicago: University of Chicago Press.CrossRef Shapiro, I., Shapiro, M. D., & Wilcox, D. (2001). Measuring the value of cataract surgery. In D. M. Cutler & E. R. Berndt (Eds.), Medical care output and productivity (pp. 411–438). Chicago: University of Chicago Press.CrossRef
go back to reference Siegel, R., Naishadham, D., & Jemal, A. (2012). Cancer statistics, 2012. CA: A Cancer Journal for Clinicians,62(1), 10–29. Siegel, R., Naishadham, D., & Jemal, A. (2012). Cancer statistics, 2012. CA: A Cancer Journal for Clinicians,62(1), 10–29.
go back to reference Skinner, J. S., Staiger, D. O., & Fisher, E. S. (2006). Is technological change in medicine always worth it? The case of acute myocardial infarction. Health Affairs,25(2), w34–w47.CrossRef Skinner, J. S., Staiger, D. O., & Fisher, E. S. (2006). Is technological change in medicine always worth it? The case of acute myocardial infarction. Health Affairs,25(2), w34–w47.CrossRef
go back to reference Stewart, S., Cutler, D. M., & Rosen, A. B. (2013). US trends in quality-adjusted life expectancy from 1987 to 2008: Combining national surveys to more broadly track the health of the nation. American Journal of Public Health,103(11), e78–e87.CrossRef Stewart, S., Cutler, D. M., & Rosen, A. B. (2013). US trends in quality-adjusted life expectancy from 1987 to 2008: Combining national surveys to more broadly track the health of the nation. American Journal of Public Health,103(11), e78–e87.CrossRef
go back to reference World Health Organization. (2001). National burden of disease studies: A practical guide. Global program on evidence for health policy. WHO, Geneva. Edition 2.0, October 2001. World Health Organization. (2001). National burden of disease studies: A practical guide. Global program on evidence for health policy. WHO, Geneva. Edition 2.0, October 2001.
Metadata
Title
Using disability adjusted life years to value the treatment of thirty chronic conditions in the U.S. from 1987 to 2010: a proof of concept
Authors
Tina Highfill
Elizabeth Bernstein
Publication date
01-12-2019
Publisher
Springer US
Keyword
Care
Published in
International Journal of Health Economics and Management / Issue 3-4/2019
Print ISSN: 2199-9023
Electronic ISSN: 2199-9031
DOI
https://doi.org/10.1007/s10754-019-09266-x

Other articles of this Issue 3-4/2019

International Journal of Health Economics and Management 3-4/2019 Go to the issue